SLIT2 is frequently inactivated in lung cancer, and knockdown of SLIT2 decreases the interaction between beta-catenin and E-cadherin/SNAI1 in lung cancer cells, resulting in increased cell migration and reduced cell adhesion [13]. Here, SLIT2 is linked to lung carcinoma.